SNCA · Categories · Form 4

SNCA - SEC Form 4 insider transactions

Seneca Biopharma, Inc. (SNCA) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for SNCA

• 1823d
  SEC Form 4 filed by Williams Donald Allen

  4 - PALISADE BIO, INC. (0001357459) (Issuer)
• 1823d
  SEC Form 4: Trenschel Robert J. was granted 304,479 units of Common Stock

  4 - PALISADE BIO, INC. (0001357459) (Issuer)
• 1823d
  SEC Form 4 filed by Neal James R

  4 - PALISADE BIO, INC. (0001357459) (Issuer)
• 1823d
  SEC Form 4: Hallam Thomas was granted 1,592 units of Common Stock

  4 - PALISADE BIO, INC. (0001357459) (Issuer)
• 1823d
  SEC Form 4: Finley John David was granted 28,718 units of Common Stock

  4 - PALISADE BIO, INC. (0001357459) (Issuer)
• 1823d
  SEC Form 4 filed by Diaz Stephanie

  4 - PALISADE BIO, INC. (0001357459) (Issuer)
• 1823d
  SEC Form 4 filed by Dawson Michael John

  4 - PALISADE BIO, INC. (0001357459) (Issuer)
• 1826d
  SEC Form 4 filed by Mazzo David J

  4 - Seneca Biopharma, Inc. (0001357459) (Issuer)
• 1826d
  SEC Form 4 filed by GRAY MARY ANN

  4 - Seneca Biopharma, Inc. (0001357459) (Issuer)
• 1826d
  SEC Form 4 filed by Csimma Cristina

  4 - Seneca Biopharma, Inc. (0001357459) (Issuer)
• 1826d
  SEC Form 4 filed by Wei Binxian

  4 - Seneca Biopharma, Inc. (0001357459) (Issuer)

Other SNCA categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends